Article: St. Jude Medical Announces U.S. Commercial Release of Pacesetter Trilogy DR+ Pacemaker

Automatic and Intelligent Technology Including Auto Mode Switching is

 
 Designed to Promote Improved Clinical and Economic Outcomes 

ST. PAUL, Minn., Oct. 1 /PRNewswire/ -- St. Jude Medical, Inc. (Nasdaq-NNM: STJM) announced today U.S. commercial release of the Trilogy(TM) DR+ pacemaker developed by its cardiac rhythm management business, Pacesetter, a world leader in innovative pacing technology. The device incorporates auto mode switching. Pacesetter, located in Los Angeles, Calif., received U.S. Food and Drug Administration (FDA) approval of the device yesterday.

The first pacing system to offer true "automaticity," the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!